Palpable purpura complicated by streptococcal toxic shock syndrome resulting in limb necrosis and amputation: A case of levamisole and cocaine coingestion

Pharmacotherapy

Volumn 32, Issue 2, 2012, Pages

  Freyer, Craig W ^a   Peters, Michael ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Adverse drug reaction; Cocaine; Gangrene; Levamisole; Necrosis; Purpura

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; COCAINE; CREATININE; IMMUNOGLOBULIN G; LACTIC ACID; LEVAMISOLE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; VANCOMYCIN;

ABSCESS; ABSCESS DRAINAGE; ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; CANDIDA; CASE REPORT; CREATININE BLOOD LEVEL; ELBOW DISEASE; ELBOW INJURY; ENTEROCOCCUS FAECIUM; FEMALE; FINGER AMPUTATION; FOOT AMPUTATION; GANGRENE; GROUP A STREPTOCOCCAL INFECTION; HUMAN; HUMAN TISSUE; INTRAVENOUS ADMINISTRATION; LACTIC ACIDOSIS; LIMB AMPUTATION; LIMB DISEASE; NAUSEA; NEUTROPENIA; PURPURA; SKIN BIOPSY; SKIN NECROSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TOXIC SHOCK SYNDROME; URINALYSIS; VOMITING;

AMPUTATION; COCAINE; EXTREMITIES; FEMALE; HUMANS; LEVAMISOLE; MIDDLE AGED; NECROSIS; PALPATION; PURPURA; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84864595142     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/PHAR.1012     Document Type: Article

References (41)

1. Jonsson S, O'Meara M, Young JB. Acute cocaine poisoning importance of treating seizures and acidosis. Am J Med 1983;75:1061-4.
2. Isner JM, Estes NA III, Thompson PD, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986;315:1438-43.
3. Golbe LI, Merkin MD. Cerebral infarction in a user of freebase cocaine ("crack"). Neurology 1986;36:1602-4.
4. Friedman DR, Wolfsthal SD. Cocaine-induced pseudovasculitis. Mayo Clin Proc 2005;80:671-3.
5. Bhinder SK, Majithia V. Cocaine use and its rheumatic manifestations: a case report and discussion. Clin Rheumatol 2007;26:1192-4.
6. Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther 2010;88:408-11.
7. Erowid Crew. Cocaine adulterated with levamisole on the rise: status as of September 2009. Available from www.erowid.org/chemicals/cocaine/cocaine- article2.shtml. Accessed January 16, 2011.
8. Substance Abuse and Mental Health Services Administration. Nationwide public health alert issued concerning life-threatening risk posed by cocaine laced with veterinary antiparasite drug: SAMHSA press release, September 21, 2009. Available from http://www.samhsa.gov/newsroom/advisories/090921vet5101. aspx. Accessed June 30, 2011.
9. Powell J, Grech H, Holder J. A boy with cutaneous necrosis occurring during treatment with levamisole. Clin Exp Dermatol 2002;27:32-3.
10. European Monitoring Centre for Drugs and Drug Addiction. Levamisole as a cocaine adulterant, November 10, 2010. Available from http://www.emcdda.europa. eu/online/annual-report/2010/boxes/p66. Accessed June 30, 2011.
11. Lynch KL, Dominy SS, Graf J. Prevalence and correlation of levamisole-adulterated cocaine and severe agranulocytosis/vasculitis [abstract]. Presented at the 2010 international congress of the European Association of Poisons Centres and Clinical Toxicologists, Bordeaux, France, ay 11-14, 2010.
12. Knowles L, Buxton JA, Skuridina N, et al. Levamisole-tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct J 2009;6:1-7.
13. Raymon LP, Isenschmid DS. The possible role of levamisole in illicit cocaine preparations. J Anal Toxicol 2009;33:620-2.
14. Centers for Disease Control and Prevention. Agranulocytosis associated with cocaine use: four states, March 2008-November 2009. MMWR Morb Mortal Wkly Rep 2009;58:1381-5.
15. Available from http://www.cdc.gov.desoto.hfhs.org:2048/mmwr/preview/ mmwrhtml/mm5849a3.htm. Accessed January 16, 2011.
16. Ward JA, Bird SB, Cohen PA. Levamisole-adulterated cocaine in a Guatemalan body packer [abstract]. Presented at the 2010 international congress of the European Association of Poisons Centres and Clinical Toxicologists, Bordeaux, France, May 11-14, 2010.
17. Bertol E, Mari F, Di Milia MGD, et al. Determination of aminorex in human urine samples by GC-MS after use of levamisole. J Pharm Biomed Anal 2011;55:1186-9.
18. Spector S, Munjal I, Schmidt DE. Effects of the immunostimulant, levamisole, on opiate withdrawal and levels of endogenous opiate alkaloids and monoamine neurotransmitters in rat brain. Neuropsychopharmacology 1998;19:417-27.
19. Kouassi E, Caille G, Lery L, et al. Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos 1986;7:71-89.
20. Zhu NY, LeGatt DF, Turner AR. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 2009;150:287-9.
21. Winquist EW, Lassam NJ. Reversible thrombocytopenia with levamisole. Med Pediatr Oncol 1995;24:262-4.
22. Symoens J, Veys E, Mielants M, et al. Adverse reactions to levamisole. Cancer Treat Rep 1978;62:1721-30.
23. Walsh NMG, Green PJ, Burlingame RW, et al. Cocainerelated retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 2010;37:1212-9.
24. Farhat EK, Muirhead TT, Chaffins ML, et al. Levamisoleinduced cutaneous necrosis mimicking coagulopathy. Arch Dermatol 2010;146:1320-1.
25. Waller JM, Feramisco JD, Alberta-Wszolek L, et al. Cocaineassociated retiform purpura and neutropenia: is levamisole the culprit? J Am Acad Dermatol 2010;63:530-6.
26. Geller L, Whang TB, Mercer SE, Phelps R. Retiform purpura: a new stigmata of illicit drug use? Dermatol. Online J 2011;17:2.
27. Muirhead TT, Elde M. Toxic effects of levamisole in a cocaine user. N Engl J Med 2011;364:e52.
28. Wiesner O, Russell KA, Lee AS, et al. Antineutrophil cytoplasmic antibodies reacting with human elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 2004;50:2954-65.
29. Fritsma GA, Leikin JB, Maturen AJ, et al. Detection of anticardiolipin antibodies in patients with cocaine abuse. J Emerg Med 1991;9:37-43.
30. Kempf W, Hantschke W, Kutzner H, et al. Dermis vascular disorders. In: Kempf W, Hantschke W, Kutzner H, Burgdorf WHC. Dermatopathology. Germany: Steinkopff Verlag, 2008:71-9.
31. Hines DW, Lisowski JM, Bone RC, et al. Sepsis. In: Gorbach SL, Bartlett JG, Blacklow NR. Infectious diseases, 3rd ed. Philadelphia: Lippincott, Williams, & Wilkins, 2004:561-7.
32. Musher DM. Cutaneous manifestations of bacterial sepsis. Hosp Pract 1989;2:92.
33. Hoeger PH, Haupt G, Hoelzle E. Acute multifocal skin necrosis: synergism between invasive streptococcal infection and cocaine-induced tissue ischaemia? Acta Derm Venereol (Stockh) 1996;76:239-41.
34. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993;269:390-1.
35. Trozak DJ, Gould WM. Cocaine abuse and connective tissue disease [case report]. J Am Acad Dermatol 1984;10:525.
36. Volcy J, Magnus Nzerue C, Oderinde A, et al. Cocaineinduced acute renal failure, hemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpura. Am J Kidney Dis 2000;35:1-5.
37. Tomecki KJ, Wiekas SM. Cocaine-related bullous disease. J Am Acad Dermatol 1985;12:585-6.
38. Citron BP, Halpern M, McCarron M, et al. Necrotizing angiitis associated with drug abuse. N Engl J Med 1970;283:1003-11.
39. Jacobson JM, Hirschman SZ. Necrotizing fasciitis complicating intravenous drug abuse. Arch Intern Med 1982;142:634-5.
40. Orser B. Thrombocytopenia and cocaine abuse. Anesthesiology 1991;74:195-6.
41. Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisoletainted cocaine. Am J Clin Pathol 2010;133:466-72.